{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:50:16Z","timestamp":1791921016016,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bcp.2021.114426","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T23:29:45Z","timestamp":1611098985000},"page":"114426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Inactivation of Wnt\/\u03b2-catenin\/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4747-7095","authenticated-orcid":false,"given":"Nahla N.","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda E.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M.","family":"Abdelghafour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3887-4398","authenticated-orcid":false,"given":"Sally K.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2021.114426_b0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","volume":"118","author":"Dinarello","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.bcp.2021.114426_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"issue":"4","key":"10.1016\/j.bcp.2021.114426_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1091581815584918","article-title":"Cytokines: the good, the bad, and the deadly","volume":"34","author":"Ramani","year":"2015","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IJICMR.S10111","article-title":"Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease","volume":"2","author":"Ortega","year":"2010","journal-title":"Int. J. Interferon Cytokine Mediator Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114426_b0025","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"8","key":"10.1016\/j.bcp.2021.114426_b0030","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease","volume":"24","author":"Silverstein","year":"2009","journal-title":"Pediatric Nephrol."},{"key":"10.1016\/j.bcp.2021.114426_b0035","first-page":"221","article-title":"Effect of infliximab on renal injury due to methotrexate in rat","volume":"2015","author":"Kirba\u015f","year":"2015","journal-title":"Iran. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.bcp.2021.114426_b0040","doi-asserted-by":"crossref","first-page":"F1231","DOI":"10.1152\/ajprenal.00557.2012","article-title":"Tumor necrosis factor-\u03b1: regulation of renal function and blood pressure","volume":"304","author":"Ramseyer","year":"2013","journal-title":"Am. J. Physiol.-Renal Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114426_b0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbagen.2009.02.005","article-title":"Klotho and aging","volume":"1790","author":"Kuro-o","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-General Subjects"},{"issue":"4","key":"10.1016\/j.bcp.2021.114426_b0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.kint.2018.11.021","article-title":"Wnt\/beta-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome","volume":"95","author":"Zhao","year":"2019","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2021.114426_b0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MNH.0000000000000205","article-title":"Wnt\/\u03b2-catenin signaling and renin-angiotensin system in chronic kidney disease","volume":"25","author":"Zhou","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"6","key":"10.1016\/j.bcp.2021.114426_b0060","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bbadis.2019.01.027","article-title":"Wnt\/\u03b2-catenin regulates blood pressure and kidney injury in rats","volume":"1865","author":"Xiao","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.2009121236","article-title":"Blockade of Wnt\/\u03b2-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury","volume":"22","author":"He","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114426_b0070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2008060566","article-title":"Wnt\/\u03b2-catenin signaling promotes renal interstitial fibrosis","volume":"20","author":"He","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12882-018-1094-z","article-title":"The role of klotho in chronic kidney disease","volume":"19","author":"Zou","year":"2018","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.bcp.2021.114426_b0080","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/581631","article-title":"Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent update","volume":"2013","author":"Guo","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.bcp.2021.114426_b0085","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3109\/0886022X.2012.717490","article-title":"Protective effect of infliximab on ischemia\/reperfusion-induced damage in rat kidney","volume":"34","author":"Tasdemir","year":"2012","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1756-185X.12202","article-title":"Dose optimization of infliximab in patients with rheumatoid arthritis","volume":"17","author":"Alten","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.bcp.2021.114426_b0095","first-page":"953","article-title":"Effect of infliximab against cisplatin-induced nephrotoxicity","volume":"35","author":"Cure","year":"2014","journal-title":"Saudi Med. J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114426_b0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.etap.2015.01.002","article-title":"Tnf-\u03b1 inhibition by infliximab as a new target for the prevention of glycerol-contrast-induced nephropathy","volume":"39","author":"Saritemur","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"28","key":"10.1016\/j.bcp.2021.114426_b0105","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.2174\/092986709789105000","article-title":"Losartan chemistry and its effects via AT1 mechanisms in the kidney","volume":"16","author":"Xu","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114426_b0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cbi.2014.09.015","article-title":"Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4","volume":"223","author":"Elsherbiny","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2021.114426_b0115","article-title":"Infliximab ameliorates tumor necrosis factor-alpha exacerbated renal insulin resistance induced in rats by regulating insulin signaling pathway","volume":"172959","author":"Mohamad","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114426_b0120","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3892\/ijmm.2013.1517","article-title":"Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis","volume":"32","author":"Qi","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2021.114426_b0125","series-title":"Chronic Kidney Disease: Diagnosis and Treatment","first-page":"3","article-title":"Chronic Kidney Disease: Overview","author":"Zhou","year":"2020"},{"issue":"6","key":"10.1016\/j.bcp.2021.114426_b0130","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1111\/jcmm.14340","article-title":"Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting \u03b2-catenin activity","volume":"23","author":"Huang","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2021.114426_b0135","doi-asserted-by":"crossref","unstructured":"C.I. Szalay, K. Erd\u00e9lyi, G. K\u00f6k\u00e9ny, E. Lajt\u00e1r, M. God\u00f3, C. R\u00e9v\u00e9sz, T. Kaucs\u00e1r, N. Kiss, M. S\u00e1rk\u00f6zy, T. Csont, T. Kren\u00e1cs, G. Sz\u00e9n\u00e1si, P. Pacher, P. Hamar, Oxidative\/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain, PloS one 10 (6) (2015) e0127090-e0127090.","DOI":"10.1371\/journal.pone.0127090"},{"key":"10.1016\/j.bcp.2021.114426_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108777","article-title":"Nicorandil combats doxorubicin\u2013induced nephrotoxicity via amendment of TLR4\/P38 MAPK\/NF\u03ba-B signaling pathway","volume":"311","author":"Khames","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2021.114426_b0145","doi-asserted-by":"crossref","unstructured":"N. Wang, R.-b. Wei, P. Li, Q.-p. Li, X. Yang, Y. Yang, M.-j. Huang, R. Wang, Z. Yin, Y. Lv, X.-m. Chen, Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy, J. Renin-Angiotensin-Aldosterone Syst. 17 (2) (2016) 1470320316646884.","DOI":"10.1177\/1470320316646884"},{"issue":"3","key":"10.1016\/j.bcp.2021.114426_b0150","article-title":"Grape seed and skin extract protects kidney from doxorubicin-induced oxidative injury","volume":"29","author":"Mokni","year":"2016","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2021.114426_b0155","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.25011\/cim.v39i1.26325","article-title":"Protective effects of molsidomine against doxorubicin-induced renal damage in rats","author":"Oguz","year":"2016","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.bcp.2021.114426_b0160","unstructured":"N. Entezari Heravi, S. Hosseinian, Z. Naji Ebrahimi Yazd, M.N. Shafei, A. Ebrahimzadeh Bideskan, S. Shahraki, Z. Samadi Noshahr, F. Motejadded, F. Beheshti, R. Mohebbati, S. Parhizgar, A. Khajavi Rad, Doxorubicin-induced renal inflammation in rats: Protective role of Plantago major, Avicenna J. Phytomed. 8 (2) (2018) 179\u2013187."},{"issue":"3","key":"10.1016\/j.bcp.2021.114426_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0971-4065.111840","article-title":"Serum cystatin C as a marker of renal function in detection of early acute kidney injury","volume":"23","author":"Murty","year":"2013","journal-title":"Indian J. Nephrol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114426_b0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2215\/CJN.02760310","article-title":"Hyperfiltration affects accuracy of creatinine eGFR measurement","volume":"6","author":"Huang","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"20","key":"10.1016\/j.bcp.2021.114426_b0175","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006949","article-title":"Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"issue":"6","key":"10.1016\/j.bcp.2021.114426_b0185","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1681\/ASN.2015040449","article-title":"Sustained activation of Wnt\/\u03b2-catenin signaling drives AKI to CKD progression","volume":"27","author":"Xiao","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/kisup.2014.16","article-title":"Wnt\/\u03b2-catenin signaling and kidney fibrosis","volume":"4","author":"Tan","year":"2014","journal-title":"Kidney international supplements"},{"issue":"9","key":"10.1016\/j.bcp.2021.114426_b0195","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1681\/ASN.2009010019","article-title":"Wnt\/\u03b2-catenin signaling promotes podocyte dysfunction and albuminuria","volume":"20","author":"Dai","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114426_b0200","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.kint.2018.10.032","article-title":"Wnt\/\u03b2-catenin links oxidative stress to podocyte injury and proteinuria","volume":"95","author":"Zhou","year":"2019","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.bcp.2021.114426_b0205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1681\/ASN.2012080865","article-title":"Loss of Klotho contributes to kidney injury by derepression of Wnt\/\u03b2-catenin signaling","volume":"24","author":"Zhou","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114426_b0210","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1681\/ASN.2010101073","article-title":"The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB","volume":"22","author":"Moreno","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114426_b0215","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1210\/en.2012-1193","article-title":"TNF-\u03b1 represses \u03b2-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway","volume":"153","author":"D\u00edaz-Delf\u00edn","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2021.114426_b0220","doi-asserted-by":"crossref","unstructured":"R.D. Thurston, C.B. Larmonier, P.M. Majewski, R. Ramalingam, M. Midura-Kiela, D. Laubitz, A. Vandewalle, D.G. Besselsen, M. M\u00fchlbauer, C. Jobin, Tumor necrosis factor and interferon-\u03b3 down-regulate Klotho in mice with colitis, Gastroenterology 138 (4) (2010) 1384\u20131394. e1382.","DOI":"10.1053\/j.gastro.2009.12.002"},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00210-019-01719-x","article-title":"Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats","volume":"393","author":"Abdelrahman","year":"2020","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cyto.2013.09.015","article-title":"Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan","volume":"65","author":"Kiyohara","year":"2014","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bcp.2021.114426_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-16","article-title":"Mechanisms of tumor necrosis factor-\u03b1-induced interleukin-6 synthesis in glioma cells","volume":"7","author":"Tanabe","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bcp.2021.114426_b0240","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9632846","article-title":"Protective effects of methotrexate against proatherosclerotic cytokines: a review of the evidence","volume":"2017","author":"Mangoni","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"8","key":"10.1016\/j.bcp.2021.114426_b0245","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3899\/jrheum.081321","article-title":"The tumor necrosis factor-\u03b1-blocking agent infliximab inhibits interleukin 1\u00df (IL-1\u00df) and IL-6 gene expression in human osteoblastic cells","volume":"36","author":"Musacchio","year":"2009","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114426_b0250","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/ndt\/gfq792","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro-and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials","volume":"26","author":"Maione","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.bcp.2021.114426_b0255","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2012040390","article-title":"Mechanisms and treatment of CKD","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114426_b0260","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)64130-2","article-title":"Systemic infusion of angiotensin II into normal rats activates nuclear factor-\u03baB and AP-1 in the kidney: role of AT1 and AT2 receptors","volume":"158","author":"Ruiz-Ortega","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114426_b0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.mnh.0000203190.34643.d4","article-title":"Renal and vascular hypertension-induced inflammation: role of angiotensin II","volume":"15","author":"Ruiz-Ortega","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bcp.2021.114426_b0270","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","article-title":"Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney","volume":"62","author":"Ruiz-Ortega","year":"2002","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bcp.2021.114426_b0275","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1681\/ASN.2005070699","article-title":"Angiotensin II upregulates toll-like receptor 4 on mesangial cells","volume":"17","author":"Wolf","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2021.114426_b0280","doi-asserted-by":"crossref","unstructured":"Y. Zhao, C. Wang, X. Hong, J. Miao, Y. Liao, F.F. Hou, L. Zhou, Y.J.K.i. Liu, Wnt\/\u03b2-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome, 95 (4) (2019) 815\u2013829.","DOI":"10.1016\/j.kint.2018.11.021"},{"key":"10.1016\/j.bcp.2021.114426_b0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2021.114426_b0290","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000469841.99283.71","article-title":"Losartan effect on lowering TNF-\u03b1 serum levels in asymptomatic hyperuricemia hypertension patients","volume":"33","author":"Ali","year":"2015","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.bcp.2021.114426_b0295","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s13311-019-00723-6","article-title":"intranasal losartan decreases perivascular beta amyloid, inflammation, and the decline of neurogenesis in hypertensive rats","volume":"16","author":"Drews","year":"2019","journal-title":"Neurotherapeutics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:22:31Z","timestamp":1757769751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":59,"alternative-id":["S0006295221000228"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114426","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivation of Wnt\/\u03b2-catenin\/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114426"}}